A rating of 32 puts Baudax Bio Inc (BXRX) near the bottom of the Biotechnology industry according to InvestorsObserver. Baudax Bio Inc's score of 32 means it scores higher than 32% of stocks in the industry. Baudax Bio Inc also received an overall rating of 45, putting it above 45% of all stocks. Biotechnology is ranked 8 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 45 means the stock is more attractive than 45 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Baudax Bio Inc Stock Today?
Baudax Bio Inc (BXRX) stock is higher by 4.69% while the S&P 500 is unchanged 0% as of 9:50 AM on Monday, Jun 29. BXRX is higher by $0.21 from the previous closing price of $4.48 on volume of 152,395 shares. Over the past year the S&P 500 has fallen -2.83% while BXRX is down -33.00%. BXRX lost -$7.05 per share the over the last 12 months.
